Happy Birthday!

St0ck For Your Review – FCPGCurrent ProfileFaceprint Global Solutions (FCPG) Current Price $0.15A U.S. based-company dedicated to the goal of bringing effective security solutions to the marketplace.With violent and white-collar terrorism on the rise, companies are starving for innovative security solutions. FCPG is set to bring hot new security solutions to the industry, with currently over 40 governmental and non-governmental contracts, being negotiated.Please Review Exactly What this Company Does.Why consider Faceprint Global Solutions (FCPG)? Faceprint Global Solutions (FCPG) holds the exclusive marketing rights from Keyvelop, to sell the world�s leading encryption technology to be distributed directly to the Healthcare industry in North America.Faceprint Global Solutions has completed its biometric software that recognizes facial features of individuals entering and leaving through airports, ship yards, banks, large buildings, etc. FCPG acquired Montreal-based Apometrix Technologies, which enhances the companies mission of being a full-service provider to the multi-application smart card industry. The North American market appears ready for significant expansion of price-competitive, proven, multi-application solutions on smart cards. Apometrix’s forecast of over 300 customers and sales of more than $50 million in North America over the next five years, appears very realistic, according to company management. Faceprint Global Solutions is currently in contract negotiations with over 40 governmental agencies and businesses seeking to use their encryption, biometric, and smart-card technologies.Breaking News for Faceprint Global Solutions (FCPG) Faceprint Global Solutions (FCPG) is pleased to announce that IBM will now offer the world�s leading encryption software to its major Healthcare clients in North America.With FCPG owning the exclusive North American rights to distribute the worlds leading encryption and transmission software developed by Keyvelop, FCPG is poised to capture large volumes of sales generated by customers currently using IBM�s software in the healthcare and other industries.�This is a very positive move for FCPG and for Keyvelop,� said FCPG CEO Pierre Cote. �We are very happy about the decision to go with IBM. This is a continuation of the progress made by everyone associated with FCPG and its partners.�Buell Duncan, IBM’s general manager of ISV & Developer Relations commented, �Collaborating with Keyvelop will ensure that we develop open solutions that are easy to maintain and cost effective for our customers in the healthcare and life sciences industry.�Among other things, this new software technology which is currently being used by a number of European healthcare companies, is used to send any file, regardless of format or size. Encryption keys, evidence of transmission integrity with fingerprint calculation, time-stamping of all actions and status record updating, pre-checking sender and receiver identities, validating file opening dates are part of Keyvelop features.About FacePrint Global Solutions, Inc.FCPG operates a business, which develops and delivers a variety of technology solutions, including biometric software applications on smart cards and other support mediums (apometric solutions). FCPG�s products provide biometric solutions for identity authentication and a host of smart card- and biometrics-related hardware peripherals and software applications. Apometrix, FCPG�s wholly-owned subsidiary, combines on-card or in-chip multi-application management solutions with best-of-breed �in-card matching� biometrics. Keyvelop�s secure digital envelope solution and Apometrix�s on-card biometrics work together to produce the winning combination in the fields of security, traceability and identity management. Conclusion:The examples above show the Awesome, Earning Potential of little known Companies That Explode onto Investor�s Radar Screens. This sto,ck will not be a Secret for long. Then You May Feel the Desire to Act Right Now! And Please Watch This One Trade! GO FCPG!Disclaimer:Information within this email contains “forwardlooking statements” withinthe meaning of Section 27Aof the Securities Act of 1933 and Section 21B ofthe Securities Exchange Act of 1934. Any statements that express or involvediscussions with respect to predictions, expectations, beliefs,plans, projections, objectives, goals, assumptions or future events orperformance are not statements of historical fact and may be “forwardlooking statements”. “Forward |ooking statements” are based onexpectations, estimates and projections at the time the statements are madethat involve a number of risks and uncertainties which could cause actualresults or events to differ materially from those presently anticipated.We were paid a sum of three thousand USD to disseminate this information from ir marketing. Forward loking statements in this action may be identified through the use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”,“estimates”, “believes”, “understands” or that by statements indicatingcertain actions “may”, “could”, or “might” occur. Risk factors includegeneral economic and business conditions, the ability to acquire and developspecific projects, the ability to fund operations and changes in consumerand business consumption habits and other factors overwhich the company haslittle or no control. The publisher of this newsletter does not representthat the information contained herein are true and correct.